Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
Cosimo Galletti, María Antonietta Barbieri, Francesco Ciodaro, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 630-630
Open Access | Times Cited: 24
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
Tobias Albrecht, Martin M. Sailer, Flavia Capitani, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 5, pp. 100780-100780
Open Access | Times Cited: 23
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
Marella Reale, Giuseppe Licci, Pietro Orlando, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5023-5031
Closed Access | Times Cited: 9
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 3108-3117
Open Access | Times Cited: 6
Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients
Matteo Alicandri‐Ciufelli, Daniele Marchioni, Carlotta Pipolo, et al.
The Laryngoscope (2023) Vol. 134, Iss. 4, pp. 1556-1563
Open Access | Times Cited: 15
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52
Claus Bachert, Asif Khan, Stella E. Lee, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 3, pp. 668-678
Open Access | Times Cited: 14
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps
Marco Caminati, Eugenio De Corso, Giancarlo Ottaviano, et al.
Current Allergy and Asthma Reports (2023) Vol. 24, Iss. 1, pp. 11-23
Open Access | Times Cited: 13
Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter
Francesca Norelli, Michele Schiappoli, Gianenrico Senna, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 5
Efficacy of dupilumab in real-life settings: a STROBE study
A. Gal, R. Gravier-Dumonceau, M. Pénicaud, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4781-4788
Closed Access | Times Cited: 5
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
Giovanna Piazzetta, Nadia Lobello, Emanuela Chiarella, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 12
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report
Pietro Orlando, Giuseppe Licci, Donald Kuitche, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 3, pp. 1317-1324
Closed Access | Times Cited: 11
The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
Mona Al‐Ahmad, Asmaa Ali, Wafaa Talat, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 2, pp. 101024-101024
Closed Access
Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
Daiki Nakashima, Tsuguhisa Nakayama, Shunsuke Minagawa, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100412-100412
Open Access
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
Pietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
The Laryngoscope (2025)
Closed Access
Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes
Isaac L. Schmale, Alexander Poulakis, Audrey Abend, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3203-3210
Closed Access | Times Cited: 9
Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta‐analysis
Jenny B. Xiao, Helen Hsiao, Carlos Khalil, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 10, pp. 1618-1633
Open Access | Times Cited: 3
Real Life Observational Study of Treatment Success of Monoclonal Antibodies for Refractory Chronic Rhinosinusitis with Nasal Polyps
Kathrin Gerstacker, Manuel Christoph Ketterer, Till F. Jakob, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4374-4374
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top